Charles River Laboratories International, Inc. (CRL) stock
CRLNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 27
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30215% above fair value
$333.25+1.09 (+0.33%)
Close on Nov 18, 2026Market cap $15.91BP/E –Yield –
Charles River Laboratories International price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Charles River Laboratories International's price to sales ratio was 4.1× on Nov 11, 2026, against 2.2× a year earlier. Over the last 5 years it ranged from 1.5× to 5.5×, with a median of 2.6×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 4.1× | +1.7 |
| 2025 | Dec 31, 2025 | 2.4× | +0.1 |
| 2024 | Dec 31, 2024 | 2.3× | −0.6 |
| 2023 | Dec 29, 2023 | 2.9× | −0.1 |
| 2022 | Dec 30, 2022 | 2.9× | −2.6 |
| 2021 | Dec 31, 2021 | 5.5× | +1.1 |
| 2020 | Dec 31, 2020 | 4.4× | +1.5 |
| 2019 | Dec 31, 2019 | 2.9× | +0.4 |
| 2018 | Dec 31, 2018 | 2.5× | −0.3 |
| 2017 | Dec 29, 2017 | 2.8× | +0.5 |
| 2016 | Dec 30, 2016 | 2.3× | −0.5 |
| 2015 | Dec 31, 2015 | 2.8× | +0.4 |
| 2014 | Dec 31, 2014 | 2.4× | +0.4 |
| 2013 | Jul 31, 2013 | 1.9× | +0.3 |
| 2012 | Dec 31, 2012 | 1.6× | +0.4 |
| 2011 | Dec 30, 2011 | 1.2× | −0.6 |
| 2010 | Dec 31, 2010 | 1.8× | – |
See a number that looks wrong?